FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

51224002: Carmellose sodium (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
85343019 Carboxymethylcellulose sodium en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2620904018 Carmellose sodium en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3713809013 Carmellose sodium (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
16451000188115 carmellose sodique fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Carmellose sodium Is a Protective agent false Inferred relationship Some
Carmellose sodium Is a Protective agent false Inferred relationship Some
Carmellose sodium Is a classe d'allergènes false Inferred relationship Some
Carmellose sodium Is a allergène médicamenteux false Inferred relationship Some
Carmellose sodium Is a Carmellose false Inferred relationship Some
Carmellose sodium Is a Cellulose-derived viscosity modifier (substance) true Inferred relationship Some
Carmellose sodium This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Carmellose true Inferred relationship Some
Carmellose sodium Is a Bulk-forming laxative (substance) false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing carboxymethylcellulose sodium The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carmellose sodium Inferred relationship Some
Product containing calcium hydroxyapatite and carboxymethylcellulose sodium The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carmellose sodium Inferred relationship Some 2
Carboxymethylcellulose sodium + hydroxyapatite injectable implant 1mL syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carmellose sodium Inferred relationship Some
Product containing carboxymethylcellulose sodium in oropharyngeal dosage form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carmellose sodium Inferred relationship Some
Product containing carboxymethylcellulose sodium in parenteral dosage form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carmellose sodium Inferred relationship Some
Carmellose sodium 1% single-use eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carmellose sodium Inferred relationship Some
Product containing carmellose sodium in ophthalmic dosage form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carmellose sodium Inferred relationship Some
Carmellose sodium 0.5% eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Carmellose sodium Inferred relationship Some
Product containing precisely carmellose sodium 5 milligram/1 milliliter conventional release eye solution (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Carmellose sodium Inferred relationship Some 1
Product containing precisely carmellose sodium 5 milligram/1 milliliter conventional release eye solution (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Carmellose sodium Inferred relationship Some 1
Product containing precisely carmellose sodium 10 milligram/1 milliliter conventional release eye solution (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Carmellose sodium Inferred relationship Some 1
Product containing precisely carmellose sodium 10 milligram/1 milliliter conventional release eye solution (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Carmellose sodium Inferred relationship Some 1
Product containing precisely carmellose sodium 5 milligram/1 milliliter conventional release eye drops (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Carmellose sodium Inferred relationship Some 1
Product containing precisely carmellose sodium 5 milligram/1 milliliter conventional release eye drops (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Carmellose sodium Inferred relationship Some 1
Product containing precisely carmellose sodium 10 milligram/1 milliliter conventional release eye drops (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Carmellose sodium Inferred relationship Some 1
Product containing precisely carmellose sodium 10 milligram/1 milliliter conventional release eye drops (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Carmellose sodium Inferred relationship Some 1

This concept is not in any reference sets

Back to Start